Literature DB >> 12760564

Design of salbutamol EOP tablets from pharmacokinetics parameters.

Nuttanan Sinchaipanid1, Sansanee Pongwai, Pichet Limsuwan, Ampol Mitrevej.   

Abstract

Salbutamol elementary osmotic pump (EOP) tablets were developed, and fundamental variables affecting their release characteristics were evaluated. The effects of film thickness and compression force on drug release from the tablets containing fixed amount of sodium chloride used as osmogent were evaluated. The core tablets were directly compressed at four compression forces and coated with 3% wt/vol cellulose acetate in acetone to levels of 2%, 3%, and 4% wt/wt. Coated tablets were drilled with CO2 laser beam to form drug delivery orifice of approximately 400 microm in diameter. The drug release was found to follow zero order fashion. The release rate decreased with the increased film thickness and was not affected by the compression force or porosity. The tablets coated to 3% and 4% levels exhibited the release rates within the range calculated from pharmacokinetic data. To illustrate the effect of osmogent content, the tablets were prepared at four osmogent levels and compressed at a constant compression force. The core tablets were coated to a level of 3% wt/wt. The release rate was initially increased with osmogent content and then decreased. At higher osmogent contents, the drug fraction in soluble component was decreased and resulted in the reduction of drug release. In conclusion, film thickness and osmogents played important roles in drug release from EOP tablets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12760564     DOI: 10.1081/pdt-120018479

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  3 in total

1.  Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note.

Authors:  Pramod Kumar; Sanjay Singh; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2008-03-18       Impact factor: 3.246

2.  Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.

Authors:  Ahmed Abd-Elbary; Mina Ibrahim Tadros; Ahmed Adel Alaa-Eldin
Journal:  AAPS PharmSciTech       Date:  2011-04-09       Impact factor: 3.246

3.  Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets.

Authors:  Sadaf Farooqi; Rabia Ismail Yousuf; Muhammad Harris Shoaib; Kamran Ahmed; Sabah Ansar; Tazeen Husain
Journal:  Drug Des Devel Ther       Date:  2020-11-26       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.